Amaran Biotech X Cytiva: Advanced Aseptic Processing Technology for Protein and New Modalities Workshop

Aseptic filling is the final production stage in the pharmaceutical industry and one of the most critical steps. However, the production process for proteins and new therapeutic modalities in aseptic filling faces numerous difficulties and challenges. To further advance the pharmaceutical industry and enhance the understanding of advanced aseptic filling processes among industry professionals and experts, Amaran and Cytiva will co-host the "Advanced Aseptic Processing Technology for Proteins and New Modalities" Workshop, scheduled to be held on Thursday, November 7, 2024, in Zhubei City.

Bioconjugation

Bioconjugation is a chemical process that forms a covalent link between two molecules, at least one of which is a biomolecule. This technique has revolutionized various fields, including medicine, diagnostics, and biotechnology.

【OkinawaTimes】Amaran Biotech 横浜で開催されるBioJapan 2024に初出展

【京都新聞】Amaran Biotech 横浜で開催されるBioJapan 2024に初出展

【福井新聞】Amaran Biotech 横浜で開催されるBioJapan 2024に初出展

【每日新聞】Amaran Biotech 横浜で開催されるBioJapan 2024に初出展

【Yahoo!Finance】Amaran Biotech Makes Its Debut at BioJapan 2024 in Yokohama

【Macau Business】Amaran Biotech Makes Its Debut at BioJapan 2024 in Yokohama

Amaran Biotech Makes Its Debut at BioJapan 2024 in Yokohama

Amaran Biotech, a leading Taiwanese CDMO (Contract Development & Manufacturing Organization) offering comprehensive pharmaceutical development and manufacturing solutions, is making its debut at BioJapan 2024 in Yokohama from October 9 to 11. The company is participating as part of Taiwan’s Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) delegation. Amaran Biotech will showcase its services at the Taiwan Pavilion (Booth No. B-56), including its vaccine adjuvant AB-801 (QS-21), drug substance manufacturing, drug product manufacturing, and stability study and analytical science services. Visitors are invited to meet with Amaran Biotech's representatives at the event.

QS-21 and its Role in Adjuvant Selection for Enhancing Vaccine Efficacy

In the field of immunology and vaccine development, adjuvants are vital components that enhance the immune response elicited by vaccines. One such adjuvant, QS-21, a natural product extracted from the bark of the soap bark tree (Quillaja saponaria), is an attractive candidate for use in vaccines.

Protein Concentration Determination

Protein concentration determination is critical in the development and production of biopharmaceuticals for several reasons:

Blue Mountain System

Equipment that complies with good manufacturing practice (GMP) is essential for producing pharmaceutical products that are pure, safe and effective. The design, function, qualification and control of such equipment must meet high standards in the manufacture of these products.